Skip to main content


Volume 474: debated on Wednesday 26 March 2008

To ask the Secretary of State for Health what assessment he has made of GlaxoSmithKline's (GSK) use in the UK of negative results from Seroxat trials; and who the (a) UK and (b) non-UK based professional registrants were who had (i) managerial and (ii) clinical responsibility for GSK's nine seroxat trials involving children between 1994 and 2002. (196847)

A detailed criminal investigation was undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA), into whether GlaxoSmithKline withheld information from paediatric clinical trials of their drug Seroxat. The report on the outcome of the investigation has been published and is available in the Library and also on the MHRA website at:

The MHRA does not normally release personal data, supplied in an expectation of confidence, in accordance with Sections 38 and 40 of the Freedom of Information Act 2000.